|Mr. David J. Main||Co-Founder, Chairman, Pres & CEO||812.64k||N/A||1965|
|Mr. Kamran Alam||CFO, VP of Fin. & Corp. Sec.||492.75k||N/A||1974|
|Ms. Shelley McCloskey||VP of HR & Admin.||N/A||N/A||1960|
Aquinox Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering and developing therapeutics for conditions marked by inflammation, inflammatory pain, and blood cancers. The company was formerly known as Aquinox Pharmaceuticals (USA) Inc. and changed its name to Aquinox Pharmaceuticals, Inc. in January 2014. Aquinox Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.
Aquinox Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.